Should I Buy BMRA Stock in 2026?
Data-driven analysis and honest assessment for Biomerica Inc
Current Price: $2.56
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
P/E data not available
Declining -0%
Currently unprofitable
Financial health data limited
Negative free cash flow
No recent insider activity
Key Investment Metrics
Current Price
$2.56
P/E Ratio
N/A
Revenue Growth
-0.2%
Profit Margin
-0.7%
Market Cap
$0.0B
Dividend Yield
None
How BMRA Compares to Competitors
Understanding how BMRA stacks up against peers helps inform your investment decision.
How BMRA Compares to Peers
Upcoming Events for BMRA
+5 Reasons TO Buy BMRA
Limited data available to identify compelling buy reasons. Consider this a yellow flag.
-5 Reasons NOT to Buy BMRA
1. Company is not profitable
high riskCurrently losing money. May need to raise capital or cut operations.
2. Negative free cash flow
high riskBurning cash creates funding risk and limits shareholder returns.
3. Small-cap volatility risk
high riskMarket cap under $2B means higher volatility and lower liquidity.
4. Revenue declining 0%
medium riskShrinking revenue suggests loss of market share or weakening demand. Turnarounds are difficult.
5. Low gross margins of 13%
medium riskMargins below 30% indicate commodity-like pricing and input cost vulnerability.
Who Should Buy BMRA?
Investment Profile
Risk Level
Very High
Recommended Holding Period
5+ years (turnaround required)
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited -0% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
Very High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in BMRA, compare these Health Care peers:
Pro tip: Compare BMRA directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for BMRA
Frequently Asked Questions
What is BMRA stock price today?
BMRA (Biomerica Inc) stock is trading at $2.56 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is BMRA stock going up or down today?
BMRA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy BMRA stock now?
The decision to buy BMRA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is BMRA a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for BMRA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is BMRA stock overvalued or undervalued?
Use our DCF valuation calculator to determine if BMRA is overvalued or undervalued based on fundamental analysis and future cash flow projections.
What is BMRA's P/E ratio?
P/E ratio data for BMRA will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.
What is BMRA's market cap?
BMRA (Biomerica Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.
What is BMRA's price to book ratio?
BMRA trades at a price-to-book (P/B) ratio of 1.74, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Biomerica Inc
Full Stock Analysis
Complete BMRA overview with charts and data
Is BMRA Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how BMRA stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Biomerica Inc
Complete BMRA Analysis
Compare BMRA With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.